Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Placement Duration of Pancreatic Duct Stent Inserted During ERCP: 2 vs 4 Weeks

NCT04691674 is registered in ClinicalTrials.gov with DongGuk University as lead sponsor.

NCT NCT04691674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04691674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Placement Duration of Pancreatic Duct Stent Inserted During ERCP: 2 vs 4 Weeks
Lead sponsor
DongGuk University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
August 31, 2024
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangitis, post-ercp acute pancreatitis, stent dislodgement